{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:18:05Z","timestamp":1785860285827,"version":"3.56.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.mbc.0000220245.20036.2d","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T04:02:07Z","timestamp":1143604927000},"page":"213-216","source":"Crossref","is-referenced-by-count":21,"title":["The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant"],"prefix":"10.1097","volume":"17","author":[{"given":"Hasan","family":"Cetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Yalaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Akisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz Y","family":"Karapinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Kavakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilgun","family":"Kultursay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210203","first-page":"562","article-title":"Pulmonary physiology of the newborn","author":"Hansen","year":"1998"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s004310000578","article-title":"Pulmonary hemorrhage in preterm infants","volume":"159","author":"Finlay","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R4-8-20210203","first-page":"271","article-title":"Pulmonary complications during mechanical ventilation in the neonatal period","volume":"54","author":"Maksic","year":"2000","journal-title":"Med Arhiv"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00134-002-1489-x","article-title":"Life-threatening hemorrhage in neonates: management with recombinant activated factor VII","volume":"28","author":"Veldman","year":"2002","journal-title":"Intensive Care Med"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1365-2516.2000.00345.x","article-title":"Clinical efficacy and recovery levels of recombinant FVIIa (Novoseven\u00ae) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency","volume":"6","author":"Wong","year":"2000","journal-title":"Hemophilia"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pbc.20078","article-title":"Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus Type 7","volume":"43","author":"Tancabelic","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl","key":"R9-8-20210203","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII","volume":"1","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2001.02870.x","article-title":"High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system","volume":"114","author":"Kjalke","year":"2001","journal-title":"Br J Haematol"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.mbc.0000169224.23550.3f","article-title":"Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock","volume":"16","author":"Martinez","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","volume":"114","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2005.01078.x","article-title":"The use of recombinant factor VIIa for bleeding in paediatric practice","volume":"11","author":"Millar","year":"2005","journal-title":"Haemophilia"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200604000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:22:15Z","timestamp":1785856935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200604000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000220245.20036.2d","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}